Akeso, Inc. (HKG:9926)
74.60
+3.65 (5.14%)
Mar 28, 2025, 4:08 PM HKT
Akeso Employees
Akeso had 2,778 employees as of December 31, 2023. The number of employees increased by 437 or 18.67% compared to the previous year.
Employees
2,778
Change (1Y)
437
Growth (1Y)
18.67%
Revenue / Employee
715.37K HKD
Profits / Employee
-280.68K HKD
Market Cap
66.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,778 | 437 | 18.67% |
Dec 31, 2022 | 2,341 | 476 | 25.52% |
Dec 31, 2021 | 1,865 | 1,119 | 150.00% |
Dec 31, 2020 | 746 | 356 | 91.28% |
Dec 31, 2019 | 390 | - | - |
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 11,000 |
Hansoh Pharmaceutical Group Company | 9,123 |
WuXi Biologics | 12,740 |
JD Health International | 3,564 |
Alibaba Health Information Technology | 1,435 |
Innovent Biologics | 4,872 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,477 |
Sino Biopharmaceutical | 24,379 |
Akeso News
- 12 days ago - Chinese drug maker Akeso hailed as biotech's 'DeepSeek moment' amid US competition - Yahoo
- 12 days ago - Chinese drug maker Akeso hailed as biotech’s ‘DeepSeek moment’ amid US competition - South China Morning Post
- 4 months ago - BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential - Benzinga
- 5 months ago - Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo - Benzinga